title: Reply.
authors.affiliation: Maastricht, Netherlands.
authors.forename: Laura H P
authors.initials: LH
authors.lastname: Wielders
authors.affiliation: Maastricht, Netherlands.
authors.forename: Verena A
authors.initials: VA
authors.lastname: Lambermont
authors.affiliation: Maastricht, Netherlands.
authors.forename: Jan S A G
authors.initials: JS
authors.lastname: Schouten
authors.affiliation: Maastricht, Netherlands.
authors.forename: Frank J H M
authors.initials: FJ
authors.lastname: van den Biggelaar
authors.affiliation: Escrick, York, United Kingdom.
authors.forename: Gill
authors.initials: G
authors.lastname: Worthy
authors.affiliation: Maastricht, Netherlands.
authors.forename: Rob W P
authors.initials: RW
authors.lastname: Simons
authors.affiliation: Maastricht, Netherlands.
authors.forename: Bjorn
authors.initials: B
authors.lastname: Winkens
authors.affiliation: Maastricht, Netherlands.
authors.forename: Rudy M M A
authors.initials: RM
authors.lastname: Nuijts
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002387:Cataract Extraction / Q000009:adverse effects*; D003920:Diabetes Mellitus; D006801:Humans; D008269:Macular Edema
chemical_list: D000893:Anti-Inflammatory Agents